Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Pharmaceutical
melas
orphan disease
leigh syndrome
mitochondria
mitochondrial disease
inborn errors of energy metabolism
mitochondrial medicine
compound development and testing
Life cell quantitative imaging
midd
rare disease
Date founded
2012
Funding rounds raised
Total raised
$3.8M
from 1 investors over 1 rounds
K
Khondrion raised $3.8M on October 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)